199 related articles for article (PubMed ID: 30151986)
1. Late effects in high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell rescue.
Elzembely MM; Dahlberg AE; Pinto N; Leger KJ; Chow EJ; Park JR; Carpenter PA; Baker KS
Pediatr Blood Cancer; 2019 Jan; 66(1):e27421. PubMed ID: 30151986
[TBL] [Abstract][Full Text] [Related]
2. Tandem stem cell rescue as consolidation therapy for high-risk neuroblastoma.
Qayed M; Chiang KY; Ricketts R; Alazraki A; Tahvildari A; Haight A; George B; Esiashvili N; Katzenstein HM
Pediatr Blood Cancer; 2012 Mar; 58(3):448-52. PubMed ID: 21538822
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell transplantation rescue.
Haghiri S; Fayech C; Mansouri I; Dufour C; Pasqualini C; Bolle S; Rivollet S; Dumas A; Boumaraf A; Belhout A; Journy N; Souchard V; Vu-Bezin G; Veres C; Haddy N; De Vathaire F; Valteau-Couanet D; Fresneau B
Bone Marrow Transplant; 2021 Aug; 56(8):1984-1997. PubMed ID: 33824435
[TBL] [Abstract][Full Text] [Related]
4. Late effects in children treated with intensive multimodal therapy for high-risk neuroblastoma: high incidence of endocrine and growth problems.
Cohen LE; Gordon JH; Popovsky EY; Gunawardene S; Duffey-Lind E; Lehmann LE; Diller LR
Bone Marrow Transplant; 2014 Apr; 49(4):502-8. PubMed ID: 24442245
[TBL] [Abstract][Full Text] [Related]
5. Acute Complications After High-Dose Chemotherapy and Stem-Cell Rescue in Pediatric Patients With High-Risk Neuroblastoma Treated in Countries With Different Resources.
Elzembely MM; Park JR; Riad KF; Sayed HA; Pinto N; Carpenter PA; Baker KS; El-Haddad A
J Glob Oncol; 2018 Sep; 4():1-12. PubMed ID: 30241255
[TBL] [Abstract][Full Text] [Related]
6. Late Effects in Pediatric High-risk Neuroblastoma Survivors After Intensive Induction Chemotherapy Followed by Myeloablative Consolidation Chemotherapy and Triple Autologous Stem Cell Transplants.
Armstrong AE; Danner-Koptik K; Golden S; Schneiderman J; Kletzel M; Reichek J; Gosiengfiao Y
J Pediatr Hematol Oncol; 2018 Jan; 40(1):31-35. PubMed ID: 28538090
[TBL] [Abstract][Full Text] [Related]
7. Long-term adverse effects on dentition in children with poor-risk neuroblastoma treated with high-dose chemotherapy and autologous stem cell transplantation with or without total body irradiation.
Hölttä P; Alaluusua S; Saarinen-Pihkala UM; Wolf J; Nyström M; Hovi L
Bone Marrow Transplant; 2002 Jan; 29(2):121-7. PubMed ID: 11850706
[TBL] [Abstract][Full Text] [Related]
8. Incorporation of high-dose
Lee JW; Lee S; Cho HW; Ma Y; Yoo KH; Sung KW; Koo HH; Cho EJ; Lee SK; Lim DH
J Hematol Oncol; 2017 May; 10(1):108. PubMed ID: 28511709
[TBL] [Abstract][Full Text] [Related]
9. Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma: A Randomized Clinical Trial.
Park JR; Kreissman SG; London WB; Naranjo A; Cohn SL; Hogarty MD; Tenney SC; Haas-Kogan D; Shaw PJ; Kraveka JM; Roberts SS; Geiger JD; Doski JJ; Voss SD; Maris JM; Grupp SA; Diller L
JAMA; 2019 Aug; 322(8):746-755. PubMed ID: 31454045
[TBL] [Abstract][Full Text] [Related]
10. Long-term complications in survivors of advanced stage neuroblastoma.
Laverdière C; Cheung NK; Kushner BH; Kramer K; Modak S; LaQuaglia MP; Wolden S; Ness KK; Gurney JG; Sklar CA
Pediatr Blood Cancer; 2005 Sep; 45(3):324-32. PubMed ID: 15714447
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of a tandem autologous peripheral blood stem cell transplant regimen for high risk neuroblastoma in a cooperative group setting: a Pediatric Oncology Group study: a report from the Children's Oncology Group.
Granger M; Grupp SA; Kletzel M; Kretschmar C; Naranjo A; London WB; Diller L
Pediatr Blood Cancer; 2012 Nov; 59(5):902-7. PubMed ID: 22744917
[TBL] [Abstract][Full Text] [Related]
12. Resource utilization and toxicities after single versus tandem autologous stem cell rescue in high-risk neuroblastoma using a national administrative database.
Desai AV; Li Y; Getz K; Seif AE; Fisher B; Huang V; Aplenc R; Bagatell R
Pediatr Blood Cancer; 2018 Dec; 65(12):e27372. PubMed ID: 30070014
[TBL] [Abstract][Full Text] [Related]
13. 1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of European experience and conclusions. European Group for Blood and Marrow Transplant Registry Solid Tumour Working Party.
Philip T; Ladenstein R; Lasset C; Hartmann O; Zucker JM; Pinkerton R; Pearson AD; Klingebiel T; Garaventa A; Kremens B; Bernard JL; Rosti G; Chauvin F
Eur J Cancer; 1997 Oct; 33(12):2130-5. PubMed ID: 9516868
[TBL] [Abstract][Full Text] [Related]
14. Late effects in survivors of high-risk neuroblastoma following stem cell transplant with and without total body irradiation.
Hobbie WL; Li Y; Carlson C; Goldfarb S; Laskin B; Denburg M; Goldmuntz E; Mostoufi-Moab S; Wilkes J; Smith K; Sacks N; Szalda D; Ginsberg JP
Pediatr Blood Cancer; 2022 Mar; 69(3):e29537. PubMed ID: 34971017
[TBL] [Abstract][Full Text] [Related]
15. Tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma: results of SMC NB-2004 study.
Sung KW; Son MH; Lee SH; Yoo KH; Koo HH; Kim JY; Cho EJ; Lee SK; Choi YS; Lim DH; Kim JS; Kim DW
Bone Marrow Transplant; 2013 Jan; 48(1):68-73. PubMed ID: 22635247
[TBL] [Abstract][Full Text] [Related]
16. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.
Yalçin B; Kremer LC; Caron HN; van Dalen EC
Cochrane Database Syst Rev; 2013 Aug; (8):CD006301. PubMed ID: 23970444
[TBL] [Abstract][Full Text] [Related]
17. Endocrine consequences of neuroblastoma treatment in children: 20 years' experience of a single center.
Geurten C; Geurten M; Hoyoux C; Lebrethon MC
J Pediatr Endocrinol Metab; 2019 Apr; 32(4):347-354. PubMed ID: 30875326
[TBL] [Abstract][Full Text] [Related]
18. Toxicities of busulfan/melphalan versus carboplatin/etoposide/melphalan for high-dose chemotherapy with stem cell rescue for high-risk neuroblastoma.
Desai AV; Heneghan MB; Li Y; Bunin NJ; Grupp SA; Bagatell R; Seif AE
Bone Marrow Transplant; 2016 Sep; 51(9):1204-10. PubMed ID: 27159174
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of children with high-risk neuroblastoma: the ENSG5 trial experience.
Moreno L; Vaidya SJ; Pinkerton CR; Lewis IJ; Imeson J; Machin D; Pearson AD; ;
Pediatr Blood Cancer; 2013 Jul; 60(7):1135-40. PubMed ID: 23281263
[TBL] [Abstract][Full Text] [Related]
20. Late effects in survivors of tandem peripheral blood stem cell transplant for high-risk neuroblastoma.
Hobbie WL; Moshang T; Carlson CA; Goldmuntz E; Sacks N; Goldfarb SB; Grupp SA; Ginsberg JP
Pediatr Blood Cancer; 2008 Nov; 51(5):679-83. PubMed ID: 18623215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
